Teva Pharmaceutical Industries (TEVA) Other Working Capital Changes: 2017-2025
Historic Other Working Capital Changes for Teva Pharmaceutical Industries (TEVA) over the last 9 years, with Sep 2025 value amounting to $561.0 million.
- Teva Pharmaceutical Industries' Other Working Capital Changes rose 276.97% to $561.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$104.0 million, marking a year-over-year increase of 90.69%. This contributed to the annual value of -$1.1 billion for FY2024, which is 27.61% up from last year.
- As of Q3 2025, Teva Pharmaceutical Industries' Other Working Capital Changes stood at $561.0 million, which was up 66.96% from $336.0 million recorded in Q2 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Other Working Capital Changes peaked at $1.1 billion during Q1 2021, and registered a low of -$4.2 billion during Q4 2021.
- In the last 3 years, Teva Pharmaceutical Industries' Other Working Capital Changes had a median value of $336.0 million in 2025 and averaged -$77.9 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Other Working Capital Changes crashed by 840.11% in 2021 and then surged by 379.25% in 2024.
- Teva Pharmaceutical Industries' Other Working Capital Changes (Quarterly) stood at -$4.2 billion in 2021, then surged by 91.62% to -$348.0 million in 2022, then plummeted by 442.82% to -$1.9 billion in 2023, then rose by 9.95% to -$1.7 billion in 2024, then surged by 276.97% to $561.0 million in 2025.
- Its Other Working Capital Changes was $561.0 million in Q3 2025, compared to $336.0 million in Q2 2025 and $700.0 million in Q1 2025.